Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048
- Citation:
- J Clin Oncol vol 36 (31) 3120-25
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Health Outcomes
- Sec. Committees:
- GI
- Pharmas:
- Novartis
- Grants:
- UG1CA189823, U10CA180821, U10CA180882, U10CA180791, U10CA180822, U10CA180838, U10CA180857, U10CA180858, U10CA180867, U10CA180868, U10CA21661, U10CA37422, HHSN261201000063C
- Corr. Author:
- Authors:
- Ethan Basch Amylou C. Dueck Lauren J. Rogak Sandra A. Mitchell Lori M. Minasian Andrea M. Denicoff Jennifer K. Wind Mary C. Shaw Narre Heon Qian Shi Brenda Ginos Garth D. Nelson Jeffrey P. Meyers George J. Chang Harvey J. Mamon Martin R. Weiser Tatjana Kolevska Bryce B. Reeve Deborah Watkins Bruner Deborah Schrag
- Networks:
- KAISER, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, LAPS-TX035, SCOR
- Study
- NCCTG-N1048
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2/3
- Keywords: